DrugPatentWatch Archives
Click here to return to the current data set
|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Generic Name: CETRORELIX
Clinical Trials for: CETRORELIXCetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) Status: Completed Condition: Benign Prostatic Hypertrophy Cetrorelix Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) Status: Terminated Condition: Benign Prostatic Hypertrophy Analysis of Two Therapeutic With Cetrotide® in PolyCystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART) Status: Active, not recruiting Condition: Polycystic Ovary Syndrome Cetrotide Treatment Optimization Status: Terminated Condition: In Vitro Fertilization; Intracytoplasmic Sperm Injection Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) Status: Completed Condition: Benign Prostatic Hypertrophy An Observational Study of Cetrotide® Gonadotropin-releasing Hormone Antagonist (GnRH Antagonist) With GONAL-f® in Assisted Reproductive Technologies (ART) Status: Completed Condition: Infertility A Multinational, Randomized, Double-Blind, Placebo‑Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis Status: Completed Condition: Endometriosis The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors Status: Completed Condition: Ovarian Hyperstimulation Syndrome Clinical Pharmacological Study of GnRH Antagonist, Cetrorelix for Healthy Female Volunteer Status: Completed Condition: Premenopause Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity Status: Recruiting Condition: Infertility Courtesy of ClinicalTrials.org See more clinical trials for this drug | |
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Patent Expiration | Patented / Exclusive Use | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Serono Inc | CETROTIDE | cetrorelix | INJECTABLE; INJECTION | 021197 | Aug 11, 2000 | RX | Yes | <disabled> | NEW CHEMICAL ENTITY | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Serono Inc | CETROTIDE | cetrorelix | INJECTABLE; INJECTION | 021197 | Aug 11, 2000 | RX | Yes | 4,800,191 | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Serono Inc | CETROTIDE | cetrorelix | INJECTABLE; INJECTION | 021197 | Aug 11, 2000 | RX | Yes | 5,198,533 | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Serono Inc | CETROTIDE | cetrorelix | INJECTABLE; INJECTION | 021197 | Aug 11, 2000 | RX | Yes | 6,319,192 | <disabled> | PREVENTION OF PREMATURE LH SURGES IN WOMEN UNDERGOING CONTROLLED OVARIAN STIMULATION | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc